Early diagnosis of brain tumours through biofluid metabolomics
Objectives: Over 20% of cancer patients develop brain metastases. Current MRI diagnostic techniques only detect late stage metastases, since they rely on blood-brain-barrier permeability to allow contrast enhancement. Thus, new methods enabling earlier diagnosis are urgently needed. We have previous...
Príomhchruthaitheoirí: | Larkin, J, Dickens, A, Claridge, T, Anthony, D, Sibson, N |
---|---|
Formáid: | Conference item |
Foilsithe / Cruthaithe: |
SAGE Publications
2016
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Early diagnosis of brain metastases through biofluid metabolomics
de réir: Larkin, JR, et al.
Foilsithe / Cruthaithe: (2017) -
Early diagnosis of brain metastases using a biofluids-metabolomics approach in mice
de réir: Larkin, J, et al.
Foilsithe / Cruthaithe: (2016) -
Biofluid analysis to differentiate brain disease
de réir: Dickens, A, et al.
Foilsithe / Cruthaithe: (2012) -
NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.
de réir: Dickens, A, et al.
Foilsithe / Cruthaithe: (2015) -
NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis
de réir: Dickens, A, et al.
Foilsithe / Cruthaithe: (2015)